南达科塔州隆突性皮肤纤维肉瘤的治疗。

Q4 Medicine
Joseph H Kelly, Marcus L Frohm
{"title":"南达科塔州隆突性皮肤纤维肉瘤的治疗。","authors":"Joseph H Kelly, Marcus L Frohm","doi":"","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Dermatofibrosarcoma protuberans (DFSP) is a rare, locally aggressive dermal soft tissue sarcoma. Local recurrences, reported at rates between 2-19%, risk sarcomatous transformation and increasing risk for metastasis. Swift diagnosis and appropriate management mitigate the risk of advanced local disease, extensive surgical resection, and subsequent risk of metastasis. Clinically, DFSP resembles multiple, common subcutaneous growths. Misdiagnosis leads to incorrect or delayed treatment. This study investigates whether access to dermatology affects outcomes of DFSP treatment in South Dakota by characterizing the rates of appropriate workup, diagnosis, treatment, and recurrence rates among dermatology and non-dermatology providers.</p><p><strong>Methods: </strong>This study was a retrospective review for 24 adults with a histological DFSP diagnosis. The study evaluated three endpoints: rates of appropriate workup and diagnosis comparing dermatology and non-dermatology providers, rates of appropriate primary treatment between lesions with and without appropriate workup and diagnosis, and rates of positive margins or primary recurrence between lesions with and without appropriate primary treatment.</p><p><strong>Results: </strong>The results for the first endpoint were not statistically significant (OR = 0.13, 95% CI: 0.012 - 1.33, p = 0.0774). The data rejected the null hypothesis of the second and third endpoints, (OR = 0.065, 95% CI: 0.0062 - 0.674, p = 0.0272), respectively. Clinical tumor size did not independently impact the treatment course for DFSP (OR: 0.43, 95% CI: 0.066 - 2.80, p = 0.657). Finally, there were no metastases in any of the 24 patients.</p><p><strong>Conclusion: </strong>Patient outcomes are better when providers biopsy DFSPs on initial presentation. Without a biopsy and uncertain diagnosis prior to treatment, providers excise insufficient surgical margins. This increases overall morbidity before achieving clear surgical margins. Higher clinical suspicion for DFSP prompting appropriate biopsy prior to surgical treatment should improve patient outcomes.</p>","PeriodicalId":39219,"journal":{"name":"South Dakota medicine : the journal of the South Dakota State Medical Association","volume":"78 6","pages":"247-252"},"PeriodicalIF":0.0000,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Dermatofibrosarcoma Protuberans Treatment in South Dakota.\",\"authors\":\"Joseph H Kelly, Marcus L Frohm\",\"doi\":\"\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Introduction: </strong>Dermatofibrosarcoma protuberans (DFSP) is a rare, locally aggressive dermal soft tissue sarcoma. Local recurrences, reported at rates between 2-19%, risk sarcomatous transformation and increasing risk for metastasis. Swift diagnosis and appropriate management mitigate the risk of advanced local disease, extensive surgical resection, and subsequent risk of metastasis. Clinically, DFSP resembles multiple, common subcutaneous growths. Misdiagnosis leads to incorrect or delayed treatment. This study investigates whether access to dermatology affects outcomes of DFSP treatment in South Dakota by characterizing the rates of appropriate workup, diagnosis, treatment, and recurrence rates among dermatology and non-dermatology providers.</p><p><strong>Methods: </strong>This study was a retrospective review for 24 adults with a histological DFSP diagnosis. The study evaluated three endpoints: rates of appropriate workup and diagnosis comparing dermatology and non-dermatology providers, rates of appropriate primary treatment between lesions with and without appropriate workup and diagnosis, and rates of positive margins or primary recurrence between lesions with and without appropriate primary treatment.</p><p><strong>Results: </strong>The results for the first endpoint were not statistically significant (OR = 0.13, 95% CI: 0.012 - 1.33, p = 0.0774). The data rejected the null hypothesis of the second and third endpoints, (OR = 0.065, 95% CI: 0.0062 - 0.674, p = 0.0272), respectively. Clinical tumor size did not independently impact the treatment course for DFSP (OR: 0.43, 95% CI: 0.066 - 2.80, p = 0.657). Finally, there were no metastases in any of the 24 patients.</p><p><strong>Conclusion: </strong>Patient outcomes are better when providers biopsy DFSPs on initial presentation. Without a biopsy and uncertain diagnosis prior to treatment, providers excise insufficient surgical margins. This increases overall morbidity before achieving clear surgical margins. Higher clinical suspicion for DFSP prompting appropriate biopsy prior to surgical treatment should improve patient outcomes.</p>\",\"PeriodicalId\":39219,\"journal\":{\"name\":\"South Dakota medicine : the journal of the South Dakota State Medical Association\",\"volume\":\"78 6\",\"pages\":\"247-252\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2025-06-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"South Dakota medicine : the journal of the South Dakota State Medical Association\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"South Dakota medicine : the journal of the South Dakota State Medical Association","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

摘要

摘要:隆突性皮肤纤维肉瘤(DFSP)是一种罕见的局部侵袭性皮肤软组织肉瘤。据报道,局部复发的发生率在2-19%之间,有肉瘤转化的风险,转移的风险也在增加。迅速的诊断和适当的治疗可降低发生晚期局部疾病、广泛手术切除和随后转移的风险。临床上,DFSP类似于多发、常见的皮下生长。误诊导致不正确或延误治疗。本研究通过描述皮肤科和非皮肤科医生的适当检查、诊断、治疗和复发率,调查在南达科他州接受皮肤科治疗是否会影响DFSP治疗的结果。方法:本研究对24例组织学诊断为DFSP的成人患者进行回顾性分析。该研究评估了三个终点:比较皮肤科和非皮肤科医生的适当检查和诊断率,有和没有适当检查和诊断的病变之间的适当初级治疗率,有和没有适当初级治疗的病变之间的阳性边缘率或原发性复发率。结果:第一个终点的结果无统计学意义(OR = 0.13, 95% CI: 0.012 - 1.33, p = 0.0774)。数据分别拒绝了第二个和第三个终点的零假设(OR = 0.065, 95% CI: 0.0062 - 0.674, p = 0.0272)。临床肿瘤大小没有独立影响DFSP的治疗过程(OR: 0.43, 95% CI: 0.066 - 2.80, p = 0.657)。最后,24例患者均未出现转移。结论:当提供者在初次就诊时对dfsp进行活检时,患者的预后更好。在治疗前没有活检和不确定的诊断,提供者切除的手术切缘不够。这增加了手术边缘清晰之前的总体发病率。临床对DFSP的高度怀疑促使手术治疗前进行适当的活检应改善患者的预后。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Dermatofibrosarcoma Protuberans Treatment in South Dakota.

Introduction: Dermatofibrosarcoma protuberans (DFSP) is a rare, locally aggressive dermal soft tissue sarcoma. Local recurrences, reported at rates between 2-19%, risk sarcomatous transformation and increasing risk for metastasis. Swift diagnosis and appropriate management mitigate the risk of advanced local disease, extensive surgical resection, and subsequent risk of metastasis. Clinically, DFSP resembles multiple, common subcutaneous growths. Misdiagnosis leads to incorrect or delayed treatment. This study investigates whether access to dermatology affects outcomes of DFSP treatment in South Dakota by characterizing the rates of appropriate workup, diagnosis, treatment, and recurrence rates among dermatology and non-dermatology providers.

Methods: This study was a retrospective review for 24 adults with a histological DFSP diagnosis. The study evaluated three endpoints: rates of appropriate workup and diagnosis comparing dermatology and non-dermatology providers, rates of appropriate primary treatment between lesions with and without appropriate workup and diagnosis, and rates of positive margins or primary recurrence between lesions with and without appropriate primary treatment.

Results: The results for the first endpoint were not statistically significant (OR = 0.13, 95% CI: 0.012 - 1.33, p = 0.0774). The data rejected the null hypothesis of the second and third endpoints, (OR = 0.065, 95% CI: 0.0062 - 0.674, p = 0.0272), respectively. Clinical tumor size did not independently impact the treatment course for DFSP (OR: 0.43, 95% CI: 0.066 - 2.80, p = 0.657). Finally, there were no metastases in any of the 24 patients.

Conclusion: Patient outcomes are better when providers biopsy DFSPs on initial presentation. Without a biopsy and uncertain diagnosis prior to treatment, providers excise insufficient surgical margins. This increases overall morbidity before achieving clear surgical margins. Higher clinical suspicion for DFSP prompting appropriate biopsy prior to surgical treatment should improve patient outcomes.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
0.50
自引率
0.00%
发文量
62
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信